Monebo Technologies Issue Patent for
Sleep Monitoring System
Austin, TX, February 5, 2007: Monebo Technologies, Inc. today announced it has been issued a patent by the United States Patent and Trademark Office for its innovative approach to sleep monitoring. Monebo’s patent 7,164,941, “Method and system for contactless monitoring and evaluation of sleep states of a user,” breaks new ground in the manner in which sleep monitoring may be performed. The patent describes a device that will be utilized like a mattress pad, allowing full patient movement while sleeping.
Current methods of sleep monitoring provide polygraph recording of electroencephalograms (EEG), electrocardiograms (ECG), electro-oculograms (EOG) and other data. These tests require the patient to be tethered to multiple cables, with electrodes attached to their torso and head, often resulting in disruptive sleep patterns due to anxiety or physical discomfort. The use of this complex equipment also necessitates monitoring at a dedicated testing facility with trained technicians.
The Monebo system is designed to be embedded within two thin mattress pad layers, eliminating any direct contact between the electrodes and the patient, enabling a more relaxed and unencumbered atmosphere for sleep monitoring. The system provides continuous evaluation of cardiac activity variability, and uses this data to evaluate the sympathetic and parasympathetic activity of the nervous system, which are reliable markers of a patient’s physiologic condition. Page 2 of 2 Monebo Technologies Issued Patent for Sleep Monitoring System
“We are excited to bring this technology forward,” said Dale Misczynski, President and CEO of Monebo. “Sleep monitoring has proven to be extremely important in diagnosing and treating sleep disorders. Unfortunately, the systems of today are cumbersome to administer and require dedicated laboratories for testing. We believe an automated contactless system can offer the medical community an easier, more comfortable way for monitoring to be performed, and may enable routine monitoring to be done outside of a dedicated laboratory, perhaps even in the patient’s home setting.”